9 results

• Oxbryta Wrongful Death Lawsuit Set for Trial in Sept. 2027

  July 24, 2025

  Irvin Jackson

  A federal judge has set an Oxbryta wrongful death lawsuit to go to trial in September 2027 over claims that the recalled drug causes the very sickle cell symptoms it was supposed to prevent.

• Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025

  July 8, 2025

  Irvin Jackson

  A mediator has been appointed to oversee settlement discussions between parties involved in an Oxbryta class action lawsuit, which claims the recalled drug endangered sickle cell disease patients.

• Wrongful Death Lawsuit Links Oxbryta Side Effects to Deadly Vaso-Occlusive Crises

  June 5, 2025

  Irvin Jackson

  A wrongful death lawsuit claims a Tennessee man suffered severe Oxbryta side effects, leading to stroke, complications and death.

• Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs

  May 23, 2025

  Irvin Jackson

  A New Jersey man claims that he was hospitalized multiple times due to problems caused by the recalled sickle cell disease drug, Oxbryta.

• First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks

  May 9, 2025

  Irvin Jackson

  An Oxbryta class action lawsuit has been scheduled for trial in August 2027, but must first survive a motion to dismiss filed by manufacturers.

• Malpractice Lawsuit Alleges Side Effects of Oxbryta Caused Untimely Death

  April 15, 2025

  Irvin Jackson

  The wife of a man who allegedly died from side effects of Oxbryta has brought claims against both the makers of the recalled sickle cell treatment and the medical staff who treated him.

• After Recalling Oxbryta, Pfizer Seeks Dismissal of Class Action Brought by Former Users

  March 7, 2025

  Irvin Jackson

  Pfizer attorneys are seeking to have an Oxbryta class action lawsuit dismissed before they have to face plaintiffs before juries.

• Oxbryta Class Action Lawsuit Filed by Former Users of Sickle Cell Disease Drug Recalled in 2024

  December 30, 2024

  Irvin Jackson

  Former users of the recalled sickle cell disease drug Oxbryta have filed a class action lawsuit, claiming the manufacturer failed to warn consumers about risks associated with the medication, which can result in stroke and death.

• Oxbryta Recall Lawsuits Claim Drug Manufacturer Knew About Fatality Risks for Years

  November 8, 2024

  Russell Maas

  Although hundreds of Oxbryta fatalities were reported through the FDA's adverse event reporting system, lawsuits point out that it took Pfiizer years to issue an Oxbryta recall.